Table 2.
Variable | TASC-A n=162 | TASC-B n=97 | TASC-C n=53 | TASC-D n=31 | P* |
---|---|---|---|---|---|
Age, year | 64.60±10.09 | 65.14±9.69 | 63.87±9.37 | 67.87±7.50 | 0.292 |
Male, n % | 126 (77.8) | 93 (95.6) | 53 (100) | 31 (100) | <0.001 |
CAD, n % | 77 (47.5) | 56 (57.7) | 35 (66.0) | 24 (77.4) | 0.005 |
Smoking, n % | 73 (45.1) | 47 (48.5) | 27 (50.9) | 18 (58.1) | 0.571 |
HT, n % | 77 (47.5) | 52 (53.6) | 29 (54.7) | 16 (51.6) | 0.722 |
HL, n % | 49 (30.2) | 31 (32.0) | 23 (43.4) | 11 (35.5) | 0.353 |
LDL, mg/dL | 134.72±34.35 | 140.20±33.19 | 162.55±52.14 | 139.87±53.61 | <0.001 |
HDL, mg/dL | 38.79±6.89 | 37.62±6.11 | 35.38±5.31 | 36.77±9.51 | 0.012 |
DM, n % | 56 (34.6) | 24 (29.3) | 18 (34.0) | 9 (29.0) | 0.928 |
CRF, n % | 41 (25.3) | 17 (17.5) | 9 (17) | 3 (9.7) | 0.140 |
LVEF, % | 58.90±10.43 | 57.16±9.57 | 58.55±10.37 | 56.23±8.97 | 0.386 |
Glucose, mg/dL | 105 (33.25) | 105 (28.5) | 105 (27.5) | 103 (20) | 0.661 |
Creatinine, mg/dL | 1.00 (0.33) | 0.96 (0.36) | 1.00 (0.38) | 1.04 (0.18) | 0.410 |
GFR, ml/min/1.73 m2 | 80.55±28.10 | 85.74±31.33 | 82.65±35.12 | 77.43±16.24 | 0.437 |
Neutrophil | 4.19±1.22 | 5.21±1.30 | 5.48±1.36 | 5.70±1.21 | <0.001 |
Lymphocyte | 1.66±0.53 | 1.61±0.50 | 1.49±0.60 | 1.36±0.48 | 0.012 |
N/L ratio | 2.45 (0.89) | 3.28 (1.50) | 3.57 (2.96) | 4.23 (2.09) | <0.001 |
Chi-square, analysis of variance and Kruskal-Wallis test
CAD - coronary artery disease; CRF - chronic renal failure (Glomerular filtration rate<60 ml/min/1.73 m2); DM - diabetes mellitus; GFR - estimated glomerular filtration rate; HDL - high density lipoprotein cholesterol; HL - hyperlipdemia; HT - hypertension; LDL - low density lipoprotein cholesterol; LVEF - left ventricle ejection fraction; N/L ratio - neutrophil/lymphocyte ratio; PAD - peripheral artery disease; TASC - Trans Atlantic Inter-Society Consensus II classification
Post hoc analysis:
LDL-TASC-A vs. TASC-B p=0.699, TASC-A vs. TASC-C p<0.001, TASC-A vs. TASC-D p=.909, TASC-B vs. TASC-C p=0.005, TASC-B vs. TASC-D p=1.000, TASC-C vs. TASC-D p= 0.054
HDL-TASC-A vs. TASC-B p=0.528, TASC-A vs. TASC-C p=0.008, TASC-A vs. TASC-D p=0.423, TASC-B vs. TASC-C p=0.211, TASC-B vs. TASC-D p=0.930, TASC-C vs. TASC-D p=0.796
Neutrophil-TASC-A vs. TASC-B p<0.001, TASC-A vs. TASC-C p<0.001, TASC-A vs. TASC-D p<0.001, TASC-B vs. TASC-C p=0.582, TASC-B vs. TASC-D p=0.238, TASC-C vs. TASC-D p=0.874
Lymphocyte-TASC-A vs. TASC-B p=0.827, TASC-A vs. TASC-C p=0.19, TASC-A vs. TASC-D p=0.018, TASC-B vs. TASC-C p=0.570, TASC-B vs. TASC-D p=0.106, TASC-C vs. TASC-D p= 0.690
N/L ratio- TASC-A vs. TASC-B p<0.001, TASC-A vs. TASC-C p<0.001, TASC-A vs. TASC-D p<0.001, TASC-B vs. TASC-C p=0.044, TASC-B vs. TASC-D p=0.001, TASC-C vs. TASC-D p= 0.252